Oryon Cell Therapies Emerges from Stealth with $21M Series A to Advance Parkinson’s Treatment

March 24, 2026

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

July 9, 2026

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

July 19, 2026

Must Read

FDA Clears Jazz’s Ziihera for First-Line Treatment of HER2-Positive Gastroesophageal Cancer

August 31, 2026

Why AI Agents Will Become Every Pharmaceutical Employee’s Copilot

August 31, 2026

How Digital Twins Are Transforming Drug Development

August 31, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Ambros and Werewolf Merge as Neridronate Advances in Phase 3 Trial for CRPS-1

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Roche Licenses Hanmi’s HM17321 Obesity Candidate in Deal Worth Up to $2.3 Billion

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Why AI Agents Will Become Every Pharmaceutical Employee’s Copilot

How Digital Twins Are Transforming Drug Development

Top 10 Digital Commercial Excellence Strategies

AI-Powered Protocol Design

Insights

Reg impact assessment next in GenAI’s sights, experts claim

Editor Picks

Oryon Cell Therapies Emerges from Stealth with $21M Series A to Advance Parkinson’s Treatment

Genentech signs a $490 million breast cancer partnership and lays off 103 employees with gRED Rethink

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

Must Read

FDA Clears Jazz’s Ziihera for First-Line Treatment of HER2-Positive Gastroesophageal Cancer

Why AI Agents Will Become Every Pharmaceutical Employee’s Copilot

How Digital Twins Are Transforming Drug Development

Hot Topics

About Us

Follow Us